Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 25, 2019 08:00 ET | Source: Fulgent Genetics, Inc.

Representatives of Fulgent Genetics to Participate in the Piper Jaffray 31st Annual Healthcare Conference

TEMPLE CITY, Calif., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation...
November 13, 2019 23:15 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics Announces Pricing of Public Offering of Common Stock

TEMPLE CITY, Calif., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) (“Fulgent Genetics” or the “Company”), a provider of comprehensive genetic testing and Next Generation...
November 13, 2019 16:01 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics Announces Proposed Public Offering of Common Stock

TEMPLE CITY, Calif., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) (“Fulgent Genetics” or the “Company”), a provider of comprehensive genetic testing and Next Generation...
November 04, 2019 16:05 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics Reports Third Quarter 2019 Financial Results

Third Quarter 2019 Results: Record billable tests of 20,697, growing 272% year over yearRecord revenue of $10.3 million, growing 84% year over yearGross Margin improves 8.9 percentage points year...
October 15, 2019 08:00 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics to Announce Third Quarter 2019 Financial Results on Monday November 4, 2019

TEMPLE CITY, Calif., Oct. 15, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its third quarter 2019...
September 16, 2019 08:00 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics Launches Picture Genetics, a Consumer-Initiated Genetic Testing Offering

TEMPLE CITY, Calif., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation...
August 05, 2019 16:05 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics Reports Second Quarter 2019 Financial Results

Second Quarter 2019 Results: Record billable tests of 16,369, growing 187% year over yearRecord revenue of $8.4 million, growing 56% year over yearGross Margin improves more than 12 percentage points...
August 05, 2019 08:00 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics Names Linda Marsh to Board of Directors

TEMPLE CITY, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics”, “Fulgent” or the “company”) today announced the addition of Linda Marsh, Senior...
August 01, 2019 16:15 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics Receives Laboratory Permit and Genetic Test Approval from New York State Department of Health

TEMPLE CITY, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation...
July 22, 2019 08:00 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics to Announce Second Quarter 2019 Financial Results on Monday August 5, 2019

TEMPLE CITY, Calif., July 22, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its second quarter 2019...